Results 271 to 280 of about 274,173 (312)
Some of the next articles are maybe not open access.
Clinical cancer genomic profiling
Nature Reviews Genetics, 2021Technological innovation and rapid reduction in sequencing costs have enabled the genomic profiling of hundreds of cancer-associated genes as a component of routine cancer care. Tumour genomic profiling can refine cancer subtype classification, identify which patients are most likely to benefit from systemic therapies and screen for germline variants ...
Debyani Chakravarty, David B. Solit
openaire +2 more sources
Current Opinion in Oncology, 2002
Genetic and environmental factors are responsible for the genomic lesions that cause cancer, a complex genetic disease associated with genomic instability. Studies aimed at deciphering the lesions in cancer have focused mainly on one or a few genes, despite the genomic scope of the disease.
openaire +2 more sources
Genetic and environmental factors are responsible for the genomic lesions that cause cancer, a complex genetic disease associated with genomic instability. Studies aimed at deciphering the lesions in cancer have focused mainly on one or a few genes, despite the genomic scope of the disease.
openaire +2 more sources
2020
This chapter discusses cancer genomics, which is one of the fastest-moving areas of medical research and is having a direct impact on people's lives. Cancer is a disease in which cells divide in excess, generating a lump, known as the primary tumour. A key feature of cancer is that the cells in the lump spread, invading the neighbouring normal tissues ...
Lia Chappell +7 more
openaire +1 more source
This chapter discusses cancer genomics, which is one of the fastest-moving areas of medical research and is having a direct impact on people's lives. Cancer is a disease in which cells divide in excess, generating a lump, known as the primary tumour. A key feature of cancer is that the cells in the lump spread, invading the neighbouring normal tissues ...
Lia Chappell +7 more
openaire +1 more source
Prospecting whole cancer genomes
Nature Cancer, 2020A new suite of studies from the Pan Cancer Analysis of Whole Genomes (PCAWG) Consortium provides the most detailed resolution of cancer genomes to date, extending our knowledge of driver genes, mutational features, structural alterations and more. Kreisberg, Ideker, Mills and Meric-Bernstam discuss the foundational and translational insights gained ...
Jason F, Kreisberg +3 more
openaire +2 more sources
Genomic Instability and Cancer
Current Molecular Medicine, 2003Tumorigenesis can be viewed as an imbalance between the mechanisms of cell-cycle control and mutation rates within the genes. Genomic instability is broadly classified into microsatellite instability (MIN) associated with mutator phenotype, and chromosome instability (CIN) recognized by gross chromosomal abnormalities.
George S, Charames, Bharati, Bapat
openaire +2 more sources
2013
Ovarian cancer (OC) is a relatively frequent malignant disease with a lifetime risk approaching to approximately 1 in 70. As many as 15-25 % OC arise due to known heterozygous germ-line mutations in DNA repair genes, such as BRCA1, BRCA2, RAD51C, NBN (NBS1), BRIP, and PALB2.
openaire +2 more sources
Ovarian cancer (OC) is a relatively frequent malignant disease with a lifetime risk approaching to approximately 1 in 70. As many as 15-25 % OC arise due to known heterozygous germ-line mutations in DNA repair genes, such as BRCA1, BRCA2, RAD51C, NBN (NBS1), BRIP, and PALB2.
openaire +2 more sources
The cancer genomics and global cancer genome collaboration
Chinese Science Bulletin, 2015All cancers arise as a result of abnormalities occurring in the DNA sequence of cancer cells, and we are now stepping into an era in which it is feasible to obtain the complete DNA sequence of large cohorts of cancer patients. The International Cancer Genome Consortium (ICGC) launched in 2007 is devoted to coordinate large-scale cancer genome studies ...
Xueda Hu +3 more
openaire +1 more source
Annual Review of Genomics and Human Genetics, 2010
Cancer profiling studies have had a profound impact on our understanding of the biology of cancers in a number of ways, including providing insights into the biological heterogeneity of specific cancer types, identification of novel oncogenes and tumor suppressors, and defining pathways that interact to drive the growth of individual cancers.
Prue A, Cowin +3 more
openaire +2 more sources
Cancer profiling studies have had a profound impact on our understanding of the biology of cancers in a number of ways, including providing insights into the biological heterogeneity of specific cancer types, identification of novel oncogenes and tumor suppressors, and defining pathways that interact to drive the growth of individual cancers.
Prue A, Cowin +3 more
openaire +2 more sources
Experimental Cell Research, 1999
Fifteen years have gone by since the initial demonstrations of mammalian genomic imprinting (Barton et al. 1984; McGrath andSolter 1984; Surani et al. 1984), 7 years since the identification of specific imprinted genes in mice (DeChiara et al. 1991; Barlow et al. 1991; Bartolomei et al.
openaire +4 more sources
Fifteen years have gone by since the initial demonstrations of mammalian genomic imprinting (Barton et al. 1984; McGrath andSolter 1984; Surani et al. 1984), 7 years since the identification of specific imprinted genes in mice (DeChiara et al. 1991; Barlow et al. 1991; Bartolomei et al.
openaire +4 more sources
Proceedings of the 17th ACM SIGKDD international conference on Knowledge discovery and data mining, 2011
Throughout life, the cells in every individual accumulate many changes in the DNA inherited from his or her parents. Certain combinations of changes lead to cancer. During the last decade, the cost of DNA sequencing has been dropping by a factor of 10 every two years, making it now possible to read most of the three billion base genome from a patient's
openaire +1 more source
Throughout life, the cells in every individual accumulate many changes in the DNA inherited from his or her parents. Certain combinations of changes lead to cancer. During the last decade, the cost of DNA sequencing has been dropping by a factor of 10 every two years, making it now possible to read most of the three billion base genome from a patient's
openaire +1 more source